Funding for this research was provided by:
National Institutes of Health (U01AI089244, AI096925)
Received: 31 July 2020
Accepted: 19 February 2021
First Online: 16 April 2021
: This study used deidentified pre-existing samples obtained from the COAT trial performed in Kampala, Uganda [CitationRef removed]. The COAT trial was approved by local Ethics Committees in Kampala, Uganda: by Uganda National Council for Science and Technology, by Mulago Hospital Research and Ethics Committee and Makerere University Infectious Diseases Institute committee (Kampala). These approvals included consents for sample collection, storage, and testing for the studies performed in this manuscript. The COAT trial was approved by the University of Minnesota IRB (# 0810M49622), by the institutional review boards at the Makerere University Infectious Diseases Institute (Uganda).
: Not applicable.
: All authors: No competed or conflicts of interest reported. All authors have read and approved the manuscript.